Living adenovirus type 4 vaccine human t lymphotropic virus type iii antibodies in swedish hemophiliacs in relation to type and dosage of factor concentrate
Berntorp, E.; Jarevi, G.; Vedback, A.; Nilsson, I.M.
Thrombosis Research (Suppl 6): 18
1986
ISSN/ISBN: 0049-3848 Document Number: 420195
Document emailed within 1 workday
Related Documents
Mast, T.Christopher.; Kierstead, L.; Gupta, S.B.; Nikas, A.A.; Kallas, E.G.; Novitsky, V.; Mbewe, B.; Pitisuttithum, P.; Schechter, M.; Vardas, E.; Wolfe, N.D.; Aste-Amezaga, M.; Casimiro, D.R.; Coplan, P.; Straus, W.L.; Shiver, J.W. 2010: International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: correlates of high Ad5 titers and implications for potential HIV vaccine trials Vaccine 28(4): 950-957Kreiss, J.K.; Kitchen, L.W.; Prince, H.E.; Kasper, C.K.; Essex, M. 1985: Antibody to human T-lymphotropic virus type IIi in wives of hemophiliacs. Evidence for heterosexual transmission Annals of Internal Medicine 102(5): 623-626
Jason, J.; McDougal, J.S.; Holman, R.C.; Stein, S.F.; Lawrence, D.N.; Nicholson, J.K.; Dixon, G.; Doxey, M.; Evatt, B.L. 1985: Human T-lymphotropic retrovirus type III/lymphadenopathy-associated virus antibody. Association with hemophiliacs' immune status and blood component usage JAMA 253(23): 3409-3415
Sierra Madero, J.G.; Ponce de León, S.; Ruiz Palacios, G.; Tinoco, J.C.; Calva, J.J.; Zamora, E.E. 1986: Prevalence of antibodies against the lymphadenopathy-associated virus/human T-cell lymphotropic virus type IIi (LAV/HTLV) in a population of homosexuals in Mexico Salud Publica de Mexico 28(2): 180-185
Sierra Madero, J.G.; Ponce de León, S.; Ruiz Palacios, G.; Tinoco, J.C.; Calva, J.J.; Zamora, E.E. 1986: Prevalence of antibodies against the lymphadenopathy-associated virus/human T-cell lymphotropic virus type IIi (LAV/HTLV) in a population of homosexuals in Mexico Salud Publica de Mexico 28(2): 180-185
Su, Z.Z.; Leon, J.A.; Jiang, H.; Austin, V.N.; Zimmer, S.G.; Fisher, P.B. 1993: Wild-type adenovirus type 5 transforming genes function as transdominant suppressors of oncogenesis in mutant adenovirus type 5 transformed rat embryo fibroblast cells Cancer Research 53(8): 1929-1938
Nakao, K.; Isashiki, Y.; Uto, M.; Ohba, N.; Kawano, K. 1994: Antibodies to human T-cell lymphotropic virus type 1 in the aqueous humor of HTLV-I associated uveitis Nippon Ganka Gakkai Zasshi 98(9): 866-871
Kawanishi, T.; Itamura, S.; Saida, T.; Kameyama, M.; Hatanaka, M. 1987: Prevalence and immunological properties of antibodies reactive with human T lymphotropic virus type i (HTLV-I) in sera from multiple sclerosis patients Rinsho Shinkeigaku 27(8): 963-968
Machado, A.A.; Hirsch, I.; Figueiredo, J.F.; Martinez, R.; de Freitas-Silva, G.; Chermann, J.C.; Covas, D.T. 1996: Occurrence of false positives in tests with synthetic peptides for the analysis of antibodies against the human immunodeficiency virus type 2 (HIV-2) in Brazilian patients infected with the human immunodeficiency virus type 1 (HIV-1) Revista da Sociedade Brasileira de Medicina Tropical 29(6): 615-617
Wiktor, S.Z.; Pate, E.J.; Murphy, E.L.; Palker, T.J.; Champegnie, E.; Ramlal, A.; Cranston, B.; Hanchard, B.; Blattner, W.A. 1993: Mother-to-child transmission of human T-cell lymphotropic virus type I (HTLV-I) in Jamaica: association with antibodies to envelope glycoprotein (gp46) epitopes Journal of Acquired Immune Deficiency Syndromes 6(10): 1162-1167
Roohandeh, M.; Bamdad, T. 2011: Inactivation of Herpes Simplex Virus type 1 & Adenovirus Type 5 by Direct Electric Current at a Biocompatible Level in Vitro Clinical Laboratory 57(7-8): 489-495
Chaplygina, N.M.; Kalinina, T.I.; Gartel', A.L.; Ponomareva, T.I.; Tiunnikov, G.I. 1981: Virus sequences in the DNA of rat cells transformed by the DNA of monkey adenovirus SA7 and the DNA of human type 6 adenovirus Vestnik Akademii Meditsinskikh Nauk SSSR 2: 64-71
Dezzutti, C.S.; Frazier, D.E.; Huff, L.Y.; Stromberg, P.C.; Olsen, R.G. 1990: Subunit vaccine protects Macaca nemestrina (pig-tailed macaque) against simian T-cell lymphotropic virus type i challenge Cancer Research 50(17 Suppl): 5687s-5691s
&na, &na; ,, 1987: Immunization of Children Infected with Human T-Lymphotropic Virus type Iii/Lymphadenopathy-Associated Virus The Pediatric Infectious Disease Journal 6(2): 209-211
Nicholson, J.K.; Cross, G.D.; Callaway, C.S.; McDougal, J.S. 1986: In vitro infection of human monocytes with human T lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) Journal of Immunology 137(1): 323-329
1985: Leads from the MMWR. Heterosexual transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus JAMA 254(15): 2051-2052
Wong-Staal, F.; Shaw, G.M.; Hahn, B.H.; Salahuddin, S.Z.; Popovic, M.; Markham, P.; Redfield, R.; Gallo, R.C. 1985: Genomic diversity of human T-lymphotropic virus type III (HTLV-III) Science 229(4715): 759-762
1985: Recommendations for preventing transmission of infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus in the workplace Mmwr. Morbidity and Mortality Weekly Report 34(45): 681
Liu, W.; Zhao, D.; Wang, Z.; Li, Y.; Wang, H.; Wang, H. 2016: Construction and Immunogenicity Analysis of Herpes Simplex Virus Type 2 Glycoprotein D Recombinant Adenovirus Vaccine Bing du Xue Bao 32(3): 267-272
Lefrère, J.J. 2000: Human T-lymphotropic virus type i (HTLV-I): risk of transmission with transfusion Presse Medicale 29(20): 1134-1138